Published in Medical Letter on the CDC and FDA, September 1st, 2002
If the FDA agrees, the Essure device could become an easier method of sterilization, the most widely used form of contraception. The FDA isn't bound by its advisers' recommendations, but typically follows them.
The advisers did attach some conditions. Noting Essure can't always be inserted successfully, the panel urged FDA to require better data on the failure rate for potential patients to consider.
The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.